GGrantIndex
← Search

ORAL ZOPOLRESTAT IN SUBJECTS WITH PERIPHERAL SYMMETRICAL DIABETIC POLYNEUROPATHY

$0M01FY2001RRNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Abstract

Each subject will be treated with either placebo or zopolrestat. During a double blind therapy, complete neuroelectrophysiology evaluations will be obtained. A baseline sural nerve biopsy will be performed at the week 0 visit after all neuroelectrophysiology evaluations. The final sural nerve biopsy will be performed at week 78. Primary efficacy endpoints are sural nerve fiber density and composite neuroelectrophysiology.

View original record on NIH RePORTER →